Pr Sylvain Ladoire
- Spécialité
- Oncologue médical, expert sein et urologie
- Hôpital
- Centre Georges-François Leclerc (Dijon)
- Derniers articles
-
- How can we optimize the surgical management of the axilla in breast cancer since the MonarchE trial? (1 juil. 2025)
- Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doublet. (1 juil. 2025)
- Vepdegestrant, a PROTAC Estrogen Receptor Degrader, in Advanced Breast Cancer. (31 mai 2025)
- Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption. (7 févr. 2025)
- Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib. (1 févr. 2025)